Philip Morris buys respiratory drugs company Vectura for £1bn


Philip Morris, one of the world’s largest tobacco companies, is starting to diversify “as part of a natural evolution into a broader healthcare and wellness company”

Philip Morris International, one of the world’s largest tobacco companies and the owner of Marlboro cigarettes, has agreed to buy the FTSE 250 respiratory drugs company Vectura for £1 billion.

The cash offer, which has been recommended by Vectura’s board, values the company at 150p per share, a 10 per cent premium to the cash consideration of the offer from the private equity firm Carlyle that was agreed in May.

Read full article here.

Alex Ralph – The Times – 2021-07-09.

Want More Investigative Content?

Curate RegWatch
Curate RegWatch
In addition to our original coverage, RegWatch curates top stories on issues and impacts arising from the regulation of economic, social and environmental activity in Canada and the U.S.


Please enter your comment!
Please enter your name here


Out of Sync | Sweanor Calls For “Rethink” On Vaping at...

What’s driving Health Canada’s war on vaping? Does the regulator favour drug harm reduction over tobacco harm reduction? And is it too late to...

Vaping Coverage Get it NOW!

Sign Up for Incisive Content!

RegWatch original video is designed to move opinion. Get our videos first and be the first to share.

Your Information will never be shared with any third party